HAVN Life Sciences Inc.
HAVLF · OTC
4/30/2022 | 4/30/2021 | 4/30/2020 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$22 | -$30 | -$0 |
| Dep. & Amort. | $1 | $5 | $0 |
| Deferred Tax | $13 | $0 | $0 |
| Stock-Based Comp. | $2 | $9 | $0 |
| Change in WC | -$1 | -$1 | -$0 |
| Other Non-Cash | $0 | $7 | -$0 |
| Operating Cash Flow | -$8 | -$10 | -$0 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 |
| Net Acquisitions | -$1 | -$0 | $0 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | -$1 | -$0 | -$0 |
| Investing Cash Flow | -$2 | -$0 | -$0 |
| Financing Activities | – | – | – |
| Debt Repay. | -$0 | -$0 | $0 |
| Stock Issued | $2 | $14 | $2 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $5 | $0 |
| Financing Cash Flow | $2 | $19 | $2 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | -$8 | $8 | $2 |
| Supplemental Information | – | – | – |
| Beg. Cash | $9 | $2 | -$0 |
| End Cash | $1 | $9 | $2 |
| Free Cash Flow | -$8 | -$10 | -$0 |